Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farah J Nassar

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Pharmacology & Therapeutics|December 6, 2016
MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy predictionFarah J Nassar, Rihab Nasr, Rabih Talhouk
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2016
An Integrative Analysis of microRNA and mRNA Profiling in CML Stem CellsFarah J Nassar, Rabab El Eit, Rihab Nasr
Le Journal Medical Libanais. the Lebanese Medical Journal|November 20, 2018
CIRCULATING microRNAs: POTENTIAL BIOMARKERS IN CANCER DETECTION, DIAGNOSIS AND PROGNOSISNader Makarem, Ahmad Mourad, Farah J Nassar, et al.
Foodborne Pathogens and Disease|July 2, 2013
Effects of subinhibitory concentrations of antimicrobial agents on Escherichia coli O157:H7 Shiga toxin release and role of the SOS responseFarah J Nassar, Elias A Rahal, Ahmad Sabra, et al.
Frontiers in Cellular and Infection Microbiology|November 20, 2012
Escherichia coli O157:H7-Clinical aspects and novel treatment approachesElias A Rahal, Natalie Kazzi, Farah J Nassar, et al.
Clinical Epigenetics|May 18, 2021
Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and predictionFarah J Nassar, Zahraa S Msheik, Rihab R Nasr, et al.
Frontiers in Medicine|March 3, 2020
Peripheral Blood-Based Biopsy for Breast Cancer Risk Prediction and Early DetectionFarah J Nassar, Ghada Chamandi, Mohamad Ali Tfaily, et al.
Frontiers in Cellular and Infection Microbiology|April 9, 2015
Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotypeElias A Rahal, Sukayna M Fadlallah, Farah J Nassar, et al.
International Journal of Molecular Sciences|September 16, 2018
Ascorbic Acid in Colon Cancer: From the Basic to the Clinical ApplicationsIbrahim El Halabi, Rachelle Bejjany, Rihab Nasr, et al.
Diagnostics (Basel, Switzerland)|March 25, 2022
miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast CancerZahraa S Msheik, Farah J Nassar, Ghada Chamandi, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Pharmacology & Therapeutics|December 6, 2016
MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy predictionFarah J Nassar, Rihab Nasr, Rabih Talhouk
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2016
An Integrative Analysis of microRNA and mRNA Profiling in CML Stem CellsFarah J Nassar, Rabab El Eit, Rihab Nasr
Le Journal Medical Libanais. the Lebanese Medical Journal|November 20, 2018
CIRCULATING microRNAs: POTENTIAL BIOMARKERS IN CANCER DETECTION, DIAGNOSIS AND PROGNOSISNader Makarem, Ahmad Mourad, Farah J Nassar, et al.
Foodborne Pathogens and Disease|July 2, 2013
Effects of subinhibitory concentrations of antimicrobial agents on Escherichia coli O157:H7 Shiga toxin release and role of the SOS responseFarah J Nassar, Elias A Rahal, Ahmad Sabra, et al.
Frontiers in Cellular and Infection Microbiology|November 20, 2012
Escherichia coli O157:H7-Clinical aspects and novel treatment approachesElias A Rahal, Natalie Kazzi, Farah J Nassar, et al.
Clinical Epigenetics|May 18, 2021
Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and predictionFarah J Nassar, Zahraa S Msheik, Rihab R Nasr, et al.
Frontiers in Medicine|March 3, 2020
Peripheral Blood-Based Biopsy for Breast Cancer Risk Prediction and Early DetectionFarah J Nassar, Ghada Chamandi, Mohamad Ali Tfaily, et al.
Frontiers in Cellular and Infection Microbiology|April 9, 2015
Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotypeElias A Rahal, Sukayna M Fadlallah, Farah J Nassar, et al.
International Journal of Molecular Sciences|September 16, 2018
Ascorbic Acid in Colon Cancer: From the Basic to the Clinical ApplicationsIbrahim El Halabi, Rachelle Bejjany, Rihab Nasr, et al.
Diagnostics (Basel, Switzerland)|March 25, 2022
miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast CancerZahraa S Msheik, Farah J Nassar, Ghada Chamandi, et al.
Pageof 2